Mickael Lesurtel
Prof Mickael Lesurtel is an expert in Surgery at Beaujon Hospital (France). As of October 2026, ScienceLeadR ranks Mickael Lesurtel in the top 1% of experts worldwide for Tissue Transplantation. Mickael Lesurtel has authored 344 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 3 of them ongoing. SLR score: 1,099 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Hepatology - Oncology - Transplantation
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 344
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Predictors of morbidity and oncological benefit after liver resection with vascular reconstruction: international collaborative study from expert centres. PMID 42803787 — mortality, carcinoma, hepatocellular, hepatic veins, portal vein, liver, vena cava, inferior, operative time, transplants, morbidity, veins, cholangiocarcinoma, extrahepatic cholangiocarcinoma | BJS Open | 2026 | 0 |
| Laparoscopic left pancreatectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared to open left pancreatectomy: a single-center retrospective study. PMID 42627533 — retrospective studies, adenocarcinoma, chemoradiotherapy, therapeutics, pancreatectomy | Surg Endosc | 2026 | 0 |
| Perioperative outcomes and long-term survival following resection of gallbladder cancer in older adults: retrospective study. PMID 42536426 — gallbladder, surgical procedures, operative, retrospective studies, neoplasms, drug therapy, aged, chemotherapy, adjuvant, morbidity, gallbladder neoplasms, therapeutics, cholangiocarcinoma, chemotherapy | BJS Open | 2026 | 0 |
| Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis. PMID 42478167 — carcinoma, hepatocellular, minimally invasive surgical procedures, liver, drug-related side effects and adverse reactions, radiofrequency ablation, transplantation | Liver Int | 2026 | 1 |
| International consensus on mesopancreas and total mesopancreas excision (MESODELPHI). PMID 42436071 — liver diseases | HPB (Oxford) | 2026 | 3 |
Clinical Studies 17
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 6
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers NCT06950398 — liver diseases, research design, liver transplantation, liver, transplants, organ transplantation, transplantation | Phase 2 | Not yet recruiting | 2025 |
| Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma NCT05971628 — liver transplantation, carcinoma, hepatocellular, liver, hepatectomy, transplantation, carcinoma | N/A | Not yet recruiting | 2023 |
| Unravelling the Impact of Radiofrecuency in Liver Surgery the Key to Decrease Local Recurrence NCT05492136 — margins of excision, neoplasms, liver, hepatectomy, liver neoplasms, neoplasms, second primary, therapeutics, ischemia | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map